Bingmu Fang

427 citations
20 papers · 339 indexed · h-index 9
Topics
CAR-T cell therapy research (3 papers)Immunotherapy and Immune Responses (3 papers)Cancer-related molecular mechanisms research (3 papers)
Journals
SHILAP Revista de lepidopterologíaFrontiers in ImmunologyEuropean Journal of Immunology
Partner nations
ChinaUnited States

In The Last Decade

Bingmu Fang

19 papers receiving 338 citations

Peers

Bingmu Fang
Comparison fields: 5 of 60
  • Oncology 141
  • Molecular Biology 136
  • Immunology 98
  • Cancer Research 83
  • Hematology 39
Replace V. Bumbaširević with:
V. Bumbaširević Serbia
Kevin W. McCool United States
Won Sam Kim South Korea
Ebru Aydin Sweden
Elisa Ferrari Italy
Juan M. Barajas United States
Jan Pěnčík Austria
Lin‐wen Wu China
Bingmu Fang relative to V. Bumbaširević Serbia V. Bumbaširević's profile →
Citations per field
00.5×4.5×
V. Bumbaširević · 1×
Citations per year

Countries citing papers authored by Bingmu Fang

Since Specialization
Citations

This map shows the geographic impact of Bingmu Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingmu Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingmu Fang more than expected).

Fields of papers citing papers by Bingmu Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingmu Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingmu Fang. The network helps show where Bingmu Fang may publish in the future.

Co-authorship network of co-authors of Bingmu Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingmu Fang. A scholar is included among the top collaborators of Bingmu Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingmu Fang. Bingmu Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 13
3 5
4 62
5 0
6 10
7 3
8 27
9
UPLC‐MS/MSによる静脈内投与後のラット血漿におけるardisiacrispin Aの薬物動力学的研究【Powered by NICT】
1
10 53
11 27
12 1
13 4
14 8
15 11
16 7
17 2
18 9
19 87
20 6

About Bingmu Fang

Bingmu Fang is a scholar working on Hematology, Cancer Research and Oncology, having authored 20 papers that have together received 339 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (83 citations), Oncology (141 citations) and Immunology (98 citations). Bingmu Fang has collaborated with scholars based in China and United States. Frequent co-authors include Jinhong Jiang, Yonghua Liu, Ning Zhang, Congying Xie, Tianzheng Lou, Qiao Li, Steven K. Lundy, Yangyi Bao, Huimin Tao and Wei Cheng. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026